Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Iksung Cho, MS

Vice President, Biostatistics
Novavax, Inc.

Disclosure(s): Novavax, Inc.: employee, Stocks/Bonds (Public Company)

Poster(s):

(P-607) Immunogenicity and Tolerability of the Novavax Nanoparticle Influenza Vaccine (NIV) and COVID-Influenza Combination Vaccine (CIC)

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT